ME/CFS Science @mecfsscience.org · 04/08/20255) Link to the trial on ClinicalTrials.gov: NCT06952413. Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - National Center of Neurology and Psychiatry, Japan. clinicaltrials.gov/s... 180 0
ME/CFS Science @mecfsscience.org · 04/08/20256) And here's the link to the Norwegian phase-III Rituximab trial, published in 2019: www.acpjournals.org/... 180 0
ME/CFS Science @mecfsscience.org · 04/08/20257) Regarding dosage, we found the following info: Fluge et al. 2019 trial 2 infusions (500 mg/m2 of body surface area), 2 weeks apart followed by 4 maintenance infusions Japanese trial 4 times at weekly intervals during the first three weeks (375 mg/m^2/week iv. x 4 times) 150 0
